Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey
- PMID: 23728737
- PMCID: PMC3973129
- DOI: 10.1007/s10096-013-1899-4
Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey
Abstract
Outpatient parenteral antimicrobial therapy (OPAT) services are not well developed in the Republic of Ireland. A national programme is being instituted to standardise care. This survey aims to assess the current use of outpatient intravenous antibiotics and to quantify the needs that physicians identify in the development of a national programme. General medical consultant physicians and clinical microbiology consultants were contacted through the Royal College of Physicians of Ireland (RCPI) from April to June 2012. Data were analysed using SPSS version 20. A total of 512 physicians were contacted, of which 55 (10.7 %) responded. The majority, 38/55 (69 %), practice general internal medicine in combination with a medical specialty, 2 (4 %) general internal medicine alone, 8 (15 %) clinical microbiology and 7 (13 %) a medical specialty alone. Of those practising a medical specialty, 12 (27 %) practice infectious diseases. Seventy-four percent reported having discharged patients with intravenous antibiotics; however, 47 % did not have a designated service available. Of those with no service, 100 % identified a need for these resources. Of those responsible for an OPAT service, 56 % had not audited their service. The most common indications were skin and soft tissue infections, osteomyelitis and respiratory tract infection. Flucloxacillin was the most commonly reported antibiotic. Eleven percent responded that they never monitor laboratory studies for patients discharged with intravenous antibiotics. While OPAT services in Ireland are not well developed, patients are being discharged with intravenous antibiotics. This survey underscores the need to develop the national programme to standardise care and ensure patients receive safe and efficient therapy.
Conflict of interest statement
Similar articles
-
A national survey of infectious disease practitioners on their use of outpatient parenteral antimicrobial therapy (OPAT).Infect Dis (Lond). 2015 Jan;47(1):39-45. doi: 10.3109/00365548.2014.967290. Epub 2014 Nov 21. Infect Dis (Lond). 2015. PMID: 25415655
-
Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.Int J Antimicrob Agents. 2018 Jan;51(1):26-32. doi: 10.1016/j.ijantimicag.2017.03.016. Epub 2017 Jun 30. Int J Antimicrob Agents. 2018. PMID: 28673610
-
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23. J Antimicrob Chemother. 2015. PMID: 25538169 Review.
-
Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital.Pediatr Infect Dis J. 2013 Apr;32(4):346-9. doi: 10.1097/INF.0b013e31827ee1c2. Pediatr Infect Dis J. 2013. PMID: 23249915
-
Outpatient parenteral antimicrobial therapy today.Clin Infect Dis. 2010 Sep 15;51 Suppl 2:S198-208. doi: 10.1086/653520. Clin Infect Dis. 2010. PMID: 20731577 Review.
Cited by
-
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177. J Antimicrob Chemother. 2024. PMID: 38842523 Free PMC article. Review.
-
A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy.Heliyon. 2023 Apr 11;9(4):e15212. doi: 10.1016/j.heliyon.2023.e15212. eCollection 2023 Apr. Heliyon. 2023. PMID: 37113779 Free PMC article.
-
The impact of an infectious disease expert team on outpatient parenteral antimicrobial treatment in the Netherlands.Int J Clin Pharm. 2019 Feb;41(1):49-55. doi: 10.1007/s11096-018-0751-4. Epub 2018 Nov 26. Int J Clin Pharm. 2019. PMID: 30478489 Free PMC article.
-
Current practices in outpatient parenteral antimicrobial therapy programmes: an international multi-centre survey.JAC Antimicrob Resist. 2025 May 27;7(3):dlaf075. doi: 10.1093/jacamr/dlaf075. eCollection 2025 Jun. JAC Antimicrob Resist. 2025. PMID: 40433448 Free PMC article.
-
Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn?JAC Antimicrob Resist. 2024 Jul 19;6(4):dlae111. doi: 10.1093/jacamr/dlae111. eCollection 2024 Aug. JAC Antimicrob Resist. 2024. PMID: 39035018 Free PMC article. Review.
References
-
- Chary A, Tice AD, Martinelli LP, Liedtke LA, Plantenga MS, Strausbaugh LJ Infectious Diseases Society of America Emerging Infections Network. Experience of infectious diseases consultants with outpatient parenteral antimicrobial therapy: results of an emerging infections network survey. Clin Infect Dis. 2006;43(10):1290–1295. - PubMed
-
- Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis. 2010;51(Suppl 2):S198–S208. - PubMed
-
- Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother. 2009;64(6):1316–1324. - PubMed
-
- Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol. 1996;17(8):552–557. - PubMed
-
- Cervera C, del Río A, García L, Sala M, Almela M, Moreno A, Falces C, Mestres CA, Marco F, Robau M, Gatell JM, Miró JM Hospital Clinic Endocarditis Study Group. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study. Enferm Infecc Microbiol Clin. 2011;29(8):587–592. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous